SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as investors debate its potential as a high-volatility meme coin, with some highlighting rapid gains and accumulation patterns while others dismiss it as a pump-and-dump scheme. Community conversation is split between those aggressively promoting the coin's momentum on platforms like Phantom and Coinbase and skeptics warning of significant risks associated with the asset's low liquidity and suspicious origin.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as investors react to its recent NYSE listing and the unique opportunity to gain liquid exposure to a basket of high-profile private tech companies like Anthropic, SpaceX, and OpenAI. The community is intensely debating the stock's significant premium over its net asset value, the impact of a six-month lockup period restricting many early holders, and the potential for extreme volatility driven by a small tradable float.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense volatility as the community debates whether the stock is being intentionally suppressed by market makers through manipulation or if it is simply cooling off after a parabolic run. While retail investors remain frustrated by the stock's performance relative to its strong earnings and AI-driven HBM demand, many are looking to the upcoming S&P 100 inclusion and potential institutional accumulation as catalysts for a long-term breakout.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is currently the center of investor attention following the appointment of parks chief Josh D'Amaro as the new CEO, sparking debate over whether this leadership transition will finally resolve long-standing stock stagnation and valuation concerns. While some in the community see the move as a catalyst for a turnaround supported by strong theme park revenue, others remain skeptical, citing continued concerns over legacy media performance and the effectiveness of current growth strategies.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is currently trending following speculative reports from Betaville suggesting the company is a potential target for a multi-billion dollar M&A deal. While retail investors remain cautiously optimistic about a buyout, community discussions are heavily focused on high short interest and the stock's recent volatility as traders debate the credibility of these unconfirmed reports versus the company's long-term commercial potential.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is in the spotlight as investors analyze its latest earnings report and acquisition of World View, while community members actively debate the company's aggressive growth strategy versus ongoing cash burn. The stock's volatility is being driven by intense interest in its strategic partnerships, specifically with Palantir, and the broader demand for drone-based defense technology as geopolitical tensions remain a focal point for traders.

Robinhood Ventures Fund I invest in companies located in the United States. The fund focuses on a broad range of sectors and industries. It provides financing for early stage transactions.

Robinhood Ventures Fund I - Common shares of beneficial interest

Robinhood Ventures Fund I is currently under intense community scrutiny as investors express frustration over its lackluster debut and a significant gap between its IPO pricing and current trading levels. While some participants are holding for long-term exposure to the fund's private tech holdings, others are actively drawing negative comparisons to newer market entries, fueling a heated debate over valuation, liquidity, and Robinhood's execution of these private market products.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending following the announcement of a $500 million AI infrastructure deal with Yotta Data Services, which the community sees as major validation of the company's ability to execute on its massive project pipeline. Investors are intensely debating the firm's long-term potential versus concerns regarding share dilution, communication transparency, and the stock's persistent price decline.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing extreme volatility and a deep sell-off as investors grapple with shifting geopolitical risks and a surprising lack of safe-haven demand despite intensifying conflict in the Middle East. Community sentiment is deeply divided, with many traders frustrated by the asset's failure to hedge against market weakness while others see the current drawdown as a historic opportunity to accumulate physical metal amidst broader concerns over national debt and long-term currency devaluation.

iShares Gold Trust is an investment vehicle, which engages in owning gold transferred to the trust in exchange for shares issued by the trust. Its activities include issuing baskets of shares in exchange for the gold deposited with the custodian as consideration; selling gold as necessary to cover the sponsor’s fee, trust expenses not assumed by the sponsor and other liabilities; and delivering gold in exchange for baskets surrendered for redemption. The company was founded on January 21, 2005 and is headquartered in San Francisco, CA.

iShares Gold Trust - fractional undivided beneficial interests

iShares Gold Trust

IAU is trending as investors debate the sustainability of gold's recent pullback amid volatile geopolitical headlines and conflicting signals from the Federal Reserve regarding interest rate policy. While some community members view the current price action as a buying opportunity for long-term protection against dollar debasement and debt expansion, others are bracing for further short-term downside if the safe-haven narrative remains under pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Organogenesis $ORGO Shares Acquired by First Light Asset Management LLC

First Light Asset Management LLC lifted its stake in shares of Organogenesis (NASDAQ:ORGO - Free Report) by 10.6% during the 3rd quarter, according to the company in its most recent filing with the...

Insider Buying: Organogenesis (NASDAQ:ORGO) Director Buys 5,000 Shares of Stock

Organogenesis (NASDAQ:ORGO - Get Free Report) Director Arthur Leibowitz purchased 5,000 shares of the stock in a transaction on Monday, March 9th. The stock was acquired at an average cost of $2.68...

Michael Joseph Driscoll Buys 10,000 Shares of Organogenesis (NASDAQ:ORGO) Stock

Organogenesis (NASDAQ:ORGO - Get Free Report) Director Michael Joseph Driscoll purchased 10,000 shares of the business's stock in a transaction on Monday, March 9th. The shares were purchased at an...

Insider Buying: Organogenesis (NASDAQ:ORGO) Director Buys $13,400.00 in Stock

Organogenesis (NASDAQ:ORGO - Get Free Report) Director Arthur Leibowitz acquired 5,000 shares of the firm's stock in a transaction on Monday, March 9th. The shares were acquired at an average price...

Organogenesis (NASDAQ:ORGO) Director Michael Joseph Driscoll Purchases 10,000 Shares of Stock

Organogenesis (NASDAQ:ORGO - Get Free Report) Director Michael Joseph Driscoll bought 10,000 shares of the firm's stock in a transaction dated Monday, March 9th. The stock was purchased at an average...

Organogenesis (NASDAQ:ORGO) Upgraded by Wall Street Zen to "Buy" Rating

Wall Street Zen upgraded shares of Organogenesis from a "hold" rating to a "buy" rating in a report on Sunday...

Wall Street Zen Downgrades Organogenesis (NASDAQ:ORGO) to Hold

Wall Street Zen downgraded Organogenesis from a "strong-buy" rating to a "hold" rating in a report on Saturday...

Organogenesis Q4 Earnings Call Highlights

Organogenesis (NASDAQ:ORGO) reported record fourth-quarter 2025 results that surpassed the high end of the revenue range the company had outlined on its third-quarter call, driven primarily by...

Organogenesis (NASDAQ:ORGO) Posts Earnings Results, Beats Expectations By $0.03 EPS

Organogenesis (NASDAQ:ORGO - Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus...

Organogenesis (ORGO) to Release Quarterly Earnings on Thursday

Organogenesis (NASDAQ:ORGO) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...

Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

Current Price	$2.47
Prev Close	$2.39
Open	$2.46
Dividend Yield	0.00%
50-Day Moving Average	$3.50
Beta	1.93
Avg. Volume	601,211.49
PE Ratio	22.56

52-Week High	$7.08
52-Week Low	$2.31
Market Capitalization	$317.74M
EPS (Annual)	$0.1537
Price to Book	1.04
Revenue Per Employee	$660,619.44

ORGO
Organogenesis Holdings Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ORGO News

ORGOOrganogenesis Holdings Inc - Ordinary Shares - Class A